Company Data
Vaccinex Inc.
Ticker
VCNX
Current Price
$1.03 -8.04%
Market Cap
$2.7M
Price Target
Refer to Report
Volume
1.3K
52wk Range
$0.76 - $10.1
Overview
Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company’s product pipeline includes pepinemab (VX15), which targets Huntington’s Disease (HD) and non-small cell lung cancer (NSCLC) and also neurodegenerative disorders; VX5 Autoimmune for the treatment of MS and potentially for other autoimmune disorder; and others.